RESEARCH PAPER
Metallothioneins in neoplastic cells – distribution in subfractions
 
More details
Hide details
1
1. Department of Environmental Hygiene, Institute of Agricultural Medicine, Lublin, Poland; 2. Department of Neurosurgery and Children’s Neurosurgery Clinic, Medical University, Lublin, Poland
2
Department of Neurosurgery and Children’s Neurosurgery Clinic, Medical University, Lublin, Poland
 
J Pre Clin Clin Res. 2007;1(2):182–184
KEYWORDS
ABSTRACT
Metallothioneins are intracellular macromolecules with a high potential for binding metallic ions. They are proteins which bind metals indispensable for the organism, as well as proteins which have found their way into the body by chance as a result of environmental pollution (e.g. cadmium, lead). Further studies have shown that the content of metallothioneins rises in neoplastic cells. Apart from metals entering a cell, metallothionein synthesis induction can be triggered by some inflammatory agents or reactive forms of oxygen. It follows from the studies of metallothionein content in a cell that these proteins are present in all cellular subfractions, and the highest content of metallotioneins is present in the cytosol subfraction. It has been found that the cellular subfractions of a neoplasm are characterized by significant changes in the distribution of metallothioneins.
 
REFERENCES (33)
1.
Boon-Huat Bay B-H, Jin R, Huang J, Tan PH: Metallothionein as a prognostic biomarker in breast cancer. Exp Biol Med 2006, 231, 1516- 1521.
 
2.
Suzuki S, Masui Y, Ohnuki M, Miyakoda G, Mori T, Nakajima K, Sato: Induction of metallothionein synthesis by cilostazol in mice and in human cultured neuronal cell lines. Biol Pharm Bull 2007, 30, 791-794.
 
3.
Frassinetti S, Bronzetti G, Caltavuturo L, Cini M, Croce CD: The role of zinc in life: a review. J Environ Pathol Toxicol Oncol 2006, 25, 597- 610.
 
4.
Ebadi M, Iversen PL, Hao R, Rojas DR, Happe HK, Murrin LC, Pfeifer RF: Expression and regulation of brain metallothionein. Neurochem Int 1995, 27, 1-22.
 
5.
Floriańczyk B: Funkcja metalotionein w ustroju. Post Hig Med Dośw 1996, 50, 375-382.
 
6.
Surowiak P, Matkowski R, Materna V, Györffy B, Wojnar A, Pudelko M, Dziegiel P, Kornafel J, Zabel M: Metallothionein: Elevated metallothionein (MT) expres-sion in invasive ductal breast cancers predicts tamoxifen resistance. Histol Histopathol. 2005, 20, 1037-1044.
 
7.
Sugita K, Yamamoto O, Asahi J: Metallothionein: Immunohistochemical analysis of metallothionein expression in malignant melanoma in Japanese patients. Am J Dermatopathol 2001, 23, 29-35.
 
8.
Smith DJ, Jaggi M, Zhang W, Galich A, Du C, Sterrett SP, Smith LM, Balaji KC: Metallothioneins and resistance to cisplatin and radiation in prostate cancer. Urology 2006, 67, 1341-1347.
 
9.
Simpkins CO, H-liao Z, Gebrehiwor R, Tyndall JA, Torrence CA, Fonong T, Balderman S, Mensah E, Sokolove PM: Opposite effects of metallothionein-I and spermine on mitochondrial function. Life Sciences 1996, 58, 2091-2099.
 
10.
Tsujikawa K, Imai T, Kakutani M: Localization of metallothionein in nuclei of growing primary cultured adult rat hepatocytes. FEBS Lett 1991, 283, 239-242.
 
11.
Tujikawa K, Suzuki N, Sagawa K, Itoh M., Suguyama T, Kohama Y, Otaki N, Kimura M, Mimura T: Induction and subcellular-localization of metallothionein in regenerating rat liver. Eur J Cell Biol 1994, 63, 240-246.
 
12.
Floriańczyk B: Metallothioneins and copper level in breast cancer. Adv Clin Exp Med 2000, 9, 29-33.
 
13.
Floriańczyk B, Osuchowski J, Kaczmarczyk R, Trojanowski T, Stryjecka-Zimmer M: Influence of metallothioneins on zinc and copper distribution in brain tumours. Folia Neuropathol 2003, 41, 11-14.
 
14.
Floriańczyk B, Grzybowska L: Concentration of metallothionein and microelements in breast cancer. Polish J. Environ. Studies 2006, 15(2A), 69-71.
 
15.
Takeda A, Tamano H, Hoshino A: Elevation of hepatic levels of metallothionein during experimental carcinogenesis. Biol Trace Elem Res 1994, 41, 157-164.
 
16.
Takeda A, Tamano H, Ohnuma M, Okada S: Zn uptake by liver of rats 3’-methyl-dimethylaminoazobenzene. Nucl Med Biol 1995, 22, 351- 353.
 
17.
Kloth DM, Chin JL, Cherian MG: Induction of hepatic metallothionein I in tumor-bearing mice. Br J Cancer 1995, 71, 712-716.
 
18.
Floriańczyk B: Czynniki indukujące syntezę metalotionein. Post Hig Med Dośw 2000, 5, 687-697.
 
19.
Schroeder JJ, Cousins RJ: Interleukin 6 regulates metallothionein gene expression and zinc metabolism in hepatocyte monolayer cultures. Proc Natl Acad Sci USA 1990, 87, 3137-3141.
 
20.
Vallee BL, Galdes A: The metallobiochemistry of zinc enzymes. Adv Enzymol Relat Areas Mol Biol 1984, 56, 283-430.
 
21.
Nishimura H, Nishimura N, Tohyama C: Localization of metallothionein in the genital organs of the male rat. J Histchem Cytochem 1990, 38, 927-933.
 
22.
Schmidt CJ, Hamer DH: Cell specificity and an effect of ras on human metallothionein gene expression. Proc Natl Acad Sci USA 1986, 83, 3346-3350.
 
23.
Tashiro-Itoh T, Ichida T, Matsuda Y, Satoh T, Sugiyama M, Tanaka Y, Ichikawa T, Itoh S, Nomoto M, Asakura H: Metallothionein expression and concentration of copper and zinc are associated with tumor differentiation in hepatocellular carcinoma. Liver 1997, 17, 300-306.
 
24.
Fresno M, Wu W, Rodriquez JM, Nadji M: Localisation of metallothionein in breast carcinomas. An immunohistochemical study . Virchows Arch 1993, 423, 215-219.
 
25.
Haerslev T, Jackobsen K, Nedergaard L, Zedeler K: Immunohistochemical detection of metallothionein in primary breast carcinomas and their axillary lymph node metastasis. Pathol Res Pract 1994, 190, 675-681.
 
26.
Schmid KW, Ellis IO, Gee JMW, Darke BM, Lees WE, Kay J, Cryer A, Stark JM, Hittmair A, Ofner D, Dunser M, Margreiter R, Daxenbichler G, Nicholson RI, Bier B, Bocker W, Jasani B: Presence and possible significance of immuno-cytochemically demonstrable metallothionein over-expression in primary invasive ductal carcinoma of the breast. Virchows Arch 1993, 422, 153-159.
 
27.
Zhang R, Zhang H, Wei H, Luo X: Expression of metallothionein in invasive ductal breast cancer in relation to prognosis. J Environ Pathol Toxicol Oncol 2000, 19, 95-97.
 
28.
Floriańczyk B, Grzybowska L: Metallothionein levels in cell fractions rom breast cancer tissues. Acta Oncol 2000, 39, 141-143.
 
29.
Floriańczyk B, Osuchowski J, Kaczmarczyk R, Starosławska E, Trojanowski T: Distribution of metallothioneins in the brain neoplastic cells. Folia Neuropathol 2005, 43, 91-96.
 
30.
Włostowski T: Postnatal changes in subcellular distribution of copper, zinc and metallothionein in the liver of bank vole (Clethrionomys glareolus): a possible involvement of metallothionein and copper in cell proliferation. Comp Biochem Physiol 1992, 103, 285-290.
 
31.
Fornage AJ, Alamo I, Hollander MC: DNA damage-inducible transcripts in mammalian cells. Proc Natl Acad Sci USA 1988, 85, 8800-8804.
 
32.
Pountney DL, Kagi JHR, Vasak M: Handbook of Metal Ligand Interactions. Biol Fluids 1995, 1, 431-442.
 
33.
Klaassen CD, Choudhuri S, Mekim JM: In vitro and in vivo studies on the degradation of metallothionein. Environ Health Perspect 1994, 102(3), 141-146.
 
eISSN:1898-7516
ISSN:1898-2395